Autosomal Dominant Polycystic Kidney Disease (ADPKD) Pain Study
CompletedNot applicableNCT00571909
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
We will enroll 20 patients to evaluate the effectiveness of a new operation known as videothoracoscopic splanchnicectomy (VSPL) for management of chronic kidney pain. This study is being done to test if this procedure is effective in controlling chronic kidney pain.
Study details
- Official title
- Evaluation and Treatment of Chronic Pain in Autosomal Dominant Polycystic Kidney Disease
- Conditions
- Kidney, Polycystic, Autosomal Dominant
- Interventions
- Procedure: video thorascopic splanchnicectomy (VSPL)
- Sponsor
- Mayo Clinic
- Collaborators
- Polycystic Kidney Disease Foundation
- Start date
- 2007-05
- Primary completion
- 2016-01
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * 18 years or older * Diagnosis of Autosomal Dominant Polycystic Kidney Disease (ADPKD) * History of debilitating kidney pain for at least 6 month. Other methods of pain management will have been appropriately considered and used when feasible and indicated. * Patient fit for general anesthesia * Must be able to travel to Mayo Clinic Rochester for 3 visits * Must be able to cover the cost of the surgery and post operative care. Exclusion Criteria: * Pregnant women (must have a confirmed negative pregnancy test) * Nursing women * Creatinine \> 3mg/dl, or hemodialysis dependent * Cancer and other major systemic diseases that could prevent follow-up or data interpretation * Neurologic or psychologic conditions preventing appropriate informed consent * Uncontrolled hypertension(SBP \> 160; DBP \>100)
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT00571909